ANALYSIS OF AN AGE-STRUCTURED HIV-1 INFECTION MODEL WITH LOGISTIC TARGET CELL GROWTH
From MaRDI portal
Publication:5856519
DOI10.1142/S0218339020500229zbMath1460.92207OpenAlexW3088796278MaRDI QIDQ5856519
No author found.
Publication date: 26 March 2021
Published in: Journal of Biological Systems (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1142/s0218339020500229
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Analysis of an age structured HIV infection model with virus-to-cell infection and cell-to-cell transmission
- Global stability for an HIV/AIDS epidemic model with different latent stages and treatment
- Stability and bifurcation analysis on a three-species food chain system with two delays
- Delay differential equations: with applications in population dynamics
- The effect of vaccines on backward bifurcation in a fractional order HIV model
- Convergence results and a Poincaré-Bendixson trichotomy for asymptotically autonomous differential equations
- Introduction to functional differential equations
- Uniform persistence and permanence for non-autonomous semiflows in population biology
- An age-structured model of HIV infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells
- Global stability of an age-structure epidemic model with imperfect vaccination and relapse
- Modelling and stability of HIV/AIDS epidemic model with treatment
- Traveling waves in a nonlocal dispersal SIRH model with relapse
- Dynamics of evolutionary competition between budding and lytic viral release strategies
- Modeling cell-to-cell spread of HIV-1 with logistic target cell growth
- A Hepatitis B and C Virus Model with Age since Infection that Exhibits Backward Bifurcation
- An age-structured within-host HIV-1 infection model with virus-to-cell and cell-to-cell transmissions
- Differential equation models of some parasitic infections: Methods for the study of asymptotic behavior
- Mathematical Analysis of Age‐Structured HIV‐1 Dynamics with Combination Antiretroviral Therapy
